Placebo-controlled, double-blind, cross-over trial of growth hormone treatment in prepubertal children with chronic renal failure
- 7 September 1991
- journal article
- clinical trial
- Published by Elsevier in The Lancet
- Vol. 338 (8767) , 585-590
- https://doi.org/10.1016/0140-6736(91)90604-n
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk
This publication has 26 references indexed in Scilit:
- Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal diseaseThe Journal of Pediatrics, 1990
- Effects of Growth Hormone in Short, Slowly Growing Children without Growth Hormone DeficiencyActa Paediatrica, 1990
- Accelerated growth after recombinant human growth hormone treatment of children with chronic renal failureThe Journal of Pediatrics, 1989
- On the Construction of the Infancy‐Childhood‐Puberty Growth StandardActa Paediatrica, 1989
- Growth Hormone Treatment in Short Children ‐Short‐Term and Long‐Term Effects on GrowthActa Paediatrica, 1988
- Growth and sexual maturation in children after kidney transplantationThe Journal of Pediatrics, 1987
- Distributions and determinants of total and high-density lipoprotein cholesterol in Dutch children and young adultsPreventive Medicine, 1985
- Growth in children with chronic renal failure on conservative treatmentKidney International, 1984
- Somatomedin in growth disorders and chronic renal insufficiency in children.BMJ, 1977
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976